Topical Imiquimod in the Treatment of Conjunctival Actinic Keratosis.
作者： Megan A. Rowlands , Joseph N. Giacometti , Javier Servat , Miguel A. Materin , Flora Levin
DOI: 10.1097/IOP.0000000000000432
关键词: Keratosis 、 Topical imiquimod 、 Medicine 、 Cryotherapy 、 Basal cell 、 Ocular irritation 、 Dermatology 、 Conjunctiva 、 Actinic keratosis 、 Imiquimod 、 Surgery
摘要: Conjunctival actinic keratosis is rare and difficult to treat, as recurrences are common. Imiquimod, an immune response modulator, currently Food Drug Administration-approved for cutaneous superficial basal cell carcinomas. Emerging reports have shown it be effective in treating some periocular conjunctival lesions. The authors present a case of 68-year-old white man with recurrent involving the pretarsal conjunctiva, which was successfully treated 5% topical imiquimod following previous failure cryotherapy interferon α-2b. patient had ocular irritation that resolved on cessation treatment. To authors' knowledge, this first report being eradicated by imiquimod.
sci-hub.se 参考文章(24)
C Brindeau, N Dorot, D Barac'h, P Verin, F Leger, B Mortemousque, Kératose actinique de la conjonctive. A propos d'un cas anatomo-clinique Journal Francais D Ophtalmologie. ,vol. 21, pp. 458- 461 ,(1998)
Sasi K. Attili, Sally H. Ibbotson, Colin Fleming, Role of non-surgical therapies in the management of periocular basal cell carcinoma and squamous intra-epidermal carcinoma: a case series and review of the literature Photodermatology, Photoimmunology and Photomedicine. ,vol. 28, pp. 68- 79 ,(2012) , 10.1111/J.1600-0781.2011.00640.X
Paul A. Brannan, Heidi K. Anderson, Robert C. Kersten, Dwight R., Kulwin, Bowen disease of the eyelid successfully treated with imiquimod. Ophthalmic Plastic and Reconstructive Surgery. ,vol. 21, pp. 321- 322 ,(2005) , 10.1097/01.IOP.0000170421.07098.61
P. S. Cannon, B. O'Donnell, S. C. Huilgol, D. Selva, The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions British Journal of Ophthalmology. ,vol. 95, pp. 1682- 1685 ,(2011) , 10.1136/BJO.2009.178202
Maria Antonietta Blasi, Daniele Giammaria, Emilio Balestrazzi, Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma. American Journal of Ophthalmology. ,vol. 140, pp. 1136- 1139 ,(2005) , 10.1016/J.AJO.2005.06.057
Sudha Sudesh, Christopher J. Rapuano, Elisabeth J. Cohen, Ralph C. Eagle, Peter R. Laibson, Surgical management of ocular surface squamous neoplasms: the experience from a cornea center. Cornea. ,vol. 19, pp. 278- 283 ,(2000) , 10.1097/00003226-200005000-00004
ANN P. MURCHISON, CARL V. WASHINGTON, ALVIN R. SOLOMAN, C. ROBERT BERNARDINO, Ocular effects of imiquimod with treatment of eyelid melanoma in situ. Dermatologic Surgery. ,vol. 33, pp. 1136- 1138 ,(2007) , 10.1111/J.1524-4725.2007.33232.X
Joseph Frucht-Pery, Yaacov Rozenman, Jacob Pe’er, Topical mitomycin-c for partially excised conjunctival squamous cell carcinoma Ophthalmology. ,vol. 109, pp. 548- 552 ,(2002) , 10.1016/S0161-6420(01)00967-8
Daisy Kopera, Helmut Kerl, Visualization and treatment of subclinical actinic keratoses with topical imiquimod 5% cream: an observational study. BioMed Research International. ,vol. 2014, pp. 135916- 135916 ,(2014) , 10.1155/2014/135916
Carol L Shields, Jerry A Shields, Tumors of the conjunctiva and cornea Survey of Ophthalmology. ,vol. 49, pp. 3- 24 ,(2004) , 10.1016/J.SURVOPHTHAL.2003.10.008